The mouse skin has become the model of choice to study the regulation and function of AP-1 subunits in many physiological and pathological processes in vivo and in vitro. Genetically modi®ed mice, in vitro reconstituted skin equivalents and epidermal cell lines were established, in which AP-1-regulated genetic programs of cell proliferation, dierentiation and tumorigenesis can be analysed. Since the epidermis, as our interface with the environment, is subjected to radiation and injury, signal transduction pathways and critical AP-1 members regulating the mammalian stress response could be identi®ed. Regulated expression of important components of the cytokine network, cell surface receptors and proteases, which orchestrate the process of wound healing has been found to rely on AP-1 activity. Here we review our current knowledge on the function of AP-1 subunits and AP-1 target genes in these fascinating ®elds of skin physiology and pathology. Oncogene (2001) 20, 2413 ± 2423.
Introduction
The transcription factor AP-1 mediates gene regulation in response to a variety of extracellular stimuli including growth factors, cytokines, oncogenes, tumour promoters and chemical carcinogens (Angel and Karin, 1991; Karin et al., 1997) . AP-1 represents a heterogenous set of dimeric proteins consisting of members of the Jun, Fos and ATF families. Small dierences in sequence speci®city for individual AP-1 dimers have been observed. Moreover, once bound to DNA, the transactivation function of subunits of a given dimeric complex may vary which can be explained by dierences in phosphorylation by upstream protein kinases (see Rincon et al. this issue) as well as by protein/protein interaction with other cellular factors. In consequence, distinct sets of genes are targeted, suggesting that individual members of the AP-1 family have speci®c functions in AP-1-regulated cellular processes. Loss of function approaches in mice and analysis of cells derived from such mutants already led to the identi®cation of speci®c, non-overlapping functions of Fos, Jun and ATF proteins (see Jochum et al. this issue) .
The skin represents a very elegant, easily accessible and highly informative system to study the regulation and function of AP-1 and AP-1-regulated genes in multiple biological processes such as cell proliferation and dierentiation. It allows elucidating cell-autonomous functions of AP-1 proteins as well as AP-1-dependent genetic programs regulated by cell-cell and cell-matrix interactions, or by soluble factors acting in an autocrine or paracrine fashion. Moreover, both tissue culture and animal models have been established to determine the role of AP-1 subunits in tumour formation and progression. Since the skin functions as the outer protective barrier of a body exposed to a variety of environmental stress factors (e.g. radiation and chemical xenobiotics, injury by mechanical stress) genetic programs controlling the cellular stress response and tissue remodelling and regeneration during wound healing can be determined. This review summarises our current knowledge on the function of AP-1 members in these aspects of skin biology.
Expression of AP-1 subunits in the skin
The skin can be dissected into two major compartments, the epidermis representing the outermost skin layer, and the dermis, both of which are separated by the basal lamina. Homeostasis of the epidermis relies on a tightly regulated balance between proliferation and dierentiation. Continuous proliferation of epidermal stem cells in the stratum basale and a shift in the balance between proliferation and dierentiation in cells of the adjacent layers are a prerequisite to replace the shed material of the stratum corneum (Figure 1 ). The dierent cell layers can be classi®ed by histological means, or e.g. by abundant desmosomes as cells belonging to the spinous layer and by the presence of hyaline granula in the stratum granulosum. Importantly, typical marker genes indicative for a speci®c phase of the dierentiation process have been identi®ed. Certain members of the cytokeratin protein family, K5 and K14, are indicative for the basal layer, whereas K1 and K10 are representative of the spinous layer. Filaggrin, type I transglutaminase as well as the envelope precursor proteins involucrin and loricrin are other markers speci®cally expressed in the suprabasal layers of the skin (for review Eckert and Welter, 1996) .
While the expression pattern of AP-1 subunits in the dermis, in particular in dermal ®broblasts, has not been analysed in great detail, expression of a few family members was studied in human and mouse epidermis by both in situ hybridization and immunohistochemical analysis Rutberg et al., 1996; Schorpp-Kistner and Angel, unpublished) . During mouse embryonic development expression of c-Jun and JunB in skin becomes ®rst visible at E17.5 showing an ill-de®ned pattern of expression of c-jun in the epidermis. JunB expression was found in the super®cial stratum corneum, but not in basal layers of proliferating epidermal cells (Wilkinson et al., 1989) . In contrast, Fra-2-expressing cells were detected at E16.5 in the basal layer and the upper granular layer, but not in the stratum corneum (Carrasco and Bravo, 1995) . These data suggest that during the process of skin development (e.g. the stratum corneum ®rst arises at E16) neither c-Jun, nor JunB play a decisive role. In the epidermis of newborn mice a distinct expression pattern of Fos and Jun proteins has been described (Rutberg et al., 1996) . Expression of c-jun, junD and Fra-1 are co-ordinately expressed in the basal and spinous layers of the epidermis. Basal cells also express c-fos, junB and Fra-1, but not fosB. JunB and Fra-2 are the only AP-1 members, which are also found in the granular layer (Carrasco and Bravo, 1995; Rutberg et al., 1996;  Figure 1 ), suggesting the existence of subgroups of AP-1 target genes involved in keratinocyte proliferation and dierentiation, whose expression is modulated by distinct AP-1 subunits. Interestingly, dierences in the expression pattern of Fos and Jun proteins in mouse (newborn) and human (neonatal) epidermis (Eckert and Welter, 1996) have been detected. In human, JunB was, similar to JunD, ubiquitously expressed in all layers of the epidermis showing highest levels in the stratum basale and stratum spinosum. In contrast, c-Jun was found to be restricted to the granular layer (Figure 1) . A somewhat broader pattern was observed for c-Fos which was present in both the spinous and granular layers but seemed to be completely absent in the basal layer and the lower zone of the stratum spinosum.
Interestingly, there was only a very low degree of overlap in the expression of c-Fos and the other members of the Fos protein family, particularly FosB, suggesting subunit-speci®c regulation of target genes. FosB, Fra-1 and Fra-2 proteins were co-ordinately expressed in the spinous layer and expression of Fra-1 and Fra-2, but not FosB, was even further increased in cells of the lower zone of the stratum granulosum. (Figure 1 ; for review, Eckert and Welter, 1996) . A detailed analysis of expression of ATF proteins in the skin has yet to be performed.
Regulation and function of Fos and Jun proteins in keratinocyte proliferation and dierentiation
Signalling pathways and AP-1 target genes in skin
The distinct expression pattern of the Jun and Fos proteins in the epidermis suggests a general role for individual AP-1 subunits in cell proliferation and dierentiation. Protein interference experiments in tissue culture cells, such as expression of antisense RNA or injection of neutralizing antibodies, and generation of subunit-speci®c knock out mice and cells derived thereof have established a critical role for Fos and Jun members in these processes. This includes the negative regulatory function of c-Jun on p53, its positive eect on cyclin D1 regulation and the positive Figure 1 Expression pattern of AP-1 subunits in skin. A schematic illustration of the skin, which can be divided in the two major compartments epidermis and dermis, is shown on the left. The multi-layered structure of the epidermis forming de®ned strata re¯ects speci®c dierentiation states of epidermal keratinocytes. The pattern of expression and abundance of human and mouse cJun, JunB, JunD, c-Fos, FosB, Fra-1 and Fra-2 proteins in these layers are shown on the right. Low but signi®cant expression of most of these proteins is found in ®broblasts, which are located in the dermal compartment transcriptional regulation of p16 by JunB as reported for ®broblasts (see Jochum et al.; Shaulian and Karin, this issue) . Moreover, binding of c-Jun to Rb has been described in human keratinocyte cell lines (Nead et al., 1998) suggesting protein/protein interactions between AP-1 members and cell cycle regulators as an additional level of cell cycle control by AP-1 subunits. However, it is important to note that the general concept of c-Jun being a positive regulator of cell proliferation and of JunB (and possibly JunD) acting as an attenuator of cell cycle progression to favour dierentiation may not account for cells of the epidermis, at least in human. As described above, the proliferating cells of the basal layer do neither express c-Jun nor c-Fos, but exhibit signi®cant amounts of JunB and JunD. Surprisingly, c-Jun (and c-Fos) expression is restricted to proliferation incompetent, terminally dierentiated cells of the stratum granulosum, which express only low amounts of JunB and JunD. These ®ndings suggest that in human AP-1 subunits expressed in keratinocytes are predominantly involved in the regulation of the dierentiation program rather than in the proliferation control. On the other hand, the expression pattern of Fos and Jun proteins in mice may point to a critical role of c-Jun, JunD and Fra-1 in keratinocyte proliferation or in the early stages of dierentiation.
Additional lines of evidence for a critical role of AP-1 subunits in keratinocyte proliferation and/or dierentiation come from the increasing number of genes, which have been found to harbour AP-1 binding sites in their promoters, and which are expressed in distinct layers of the epidermis. In most cases, functional relevance of these sites for dierentiationspeci®c basal expression or for induced expression upon critical extracellular signals, e.g. levels of calcium, was con®rmed in established keratinocyte cell lines. The list of AP-1 target genes in the epidermis, which are considered to encode critical players of skin homeostasis includes transglutaminase and dierent members of the cytokeratin gene family such as K1, K5, K6, K8, K14, K18 and K19 (for references, see Eckert and Welter, 1996; Navarro et al., 1995; Hu and Gudas, 1994) . The requirement of the AP-1 site in the human K14 and K18 promoters was con®rmed in transgenic mice (Rhodes and Oshima, 1998; Sinha et al., 2000) . High basal level expression of the pro®lag-grin gene in epidermal keratinocytes depends on c-Jun/ c-Fos heterodimers (Jang et al., 1996) , whereas cooperative action of AP-1 and Sp1 is required for maximal expression of the human involucrin promoter (Lopez-Bayghen et al., 1996) . JunD, Fra-1 and Fra-2 proteins, whose levels are aected by changes in the concentration of extracellular calcium, preferentially bind to the calcium response element in this promoter (Ng et al., 2000) . However, Fra-1, JunB and JunD appear to be responsible for the regulation of involucrin promoter activity by phorbol esters . Functional synergism between AP-1 and ETS proteins was found to mediate expression of the keratinocyte terminal dierentiation markers small proline-rich protein (SPRR)-1A (Sark et al., 1998) and SPRR3 (Fischer et al., 1999) . In contrast, expression of another member of the SPRR family sprr2, is negatively regulated by c-Jun. Interestingly, this eect is likely to be indirect, since repression is mediated by a region, which diers from the AP-1 site in the sprr promoter (Lohman et al., 1997) . Transient co-transfection experiments suggested that c-Fos/JunB heterodimers are critically involved in the dierentiation-speci®c expression of loricrin. However, analysis of the loricrin promoter in transgenic mice showed that an additional negatively acting element is needed to restrict loricrin expression to the granular layer (Di Sepio et al., 1999) . Similarly, AP-1, ETS and members of the AP-2 transcription factor families, binding to two distinct promoter regions, are required to orchestrate keratinocyte-speci®c activity of the K14 promoter in transgenic mice (Sinha et al., 2000) .
In addition to this impressive and still increasing number of AP-1-regulated genes in epidermal cells, dierences in the expression pattern of AP-1 subunits during in vitro dierentiation of keratinocytes have pointed to a regulatory function of AP-1 in the formation and maintenance of the epidermis. In vitro multiple phenotypes of keratinocyte dierentiation can be recapitulated e.g. by raising the calcium concentration or treatment of cells with phorbol esters (for references see Rutberg et al., 1997) . Under such conditions speci®c alterations in the expression of Fos, Jun and AP-1 target genes (sprr1, pro®laggrin) can be detected suggesting speci®c and partially opposing functions of AP-1 subunits in keratinocyte dierentiation (Gandarillas and Watt, 1995; Rutberg et al., 1997) . Moreover, there is strong evidence that signal transduction pathways modulating AP-1 activity (see Rincor et al. this issue) are main regulators of keratinocyte proliferation and dierentiation. For example, calcium-induced terminal dierentiation depends on speci®c isoforms of PKC, and PKC activation is required for calcium-induced expression of Fra-2, JunB and JunD expression and enhanced AP-1 binding activity (Rutberg et al., 1996; Takahashi et al., 1998) . On the other hand, transdominant negative versions of MEKK1, MEK1, MEK3, MEK7, p38 and c-jun, but not mutants of the Raf/Erk or MEK4/JNK signalling pathway, interfere with TPA-dependent induction of involucrin expression (E®mova et al., 1998) . These data suggest that at least one route of the stress signal transduction pathway may also be involved in the regulation of keratinocyte dierentiation.
An additional argument for the involvement of AP-1 in skin biology is the repression of involucrin and K1, K5 and K14 gene expression by retinoids and steroid hormones, which are the most commonly used therapeutic agents in dermatology (Lu et al., 1994; Monzon et al., 1996; Radoja et al., 2000) . Although in each case repression is mediated through an AP-1 site, loss of K1 expression might be explained through competitive binding of AP-1 and steroid hormone receptors to a composite AP-1/steroid hormone receptor element (Lu et al., 1994) . Repression of the other genes is likely to be mediated by physical interaction of AP-1 with the retinoic acid or glucocorticoid receptor resulting in mutual inactivation of their transactivation functions (see Herrlich, this issue).
Role of AP-1 in wound healing
Despite this large body of data on the expression pattern of AP-1 members and potential AP-1 target genes in tissue culture cells and in the mouse, the phenotypes of mice lacking c-Fos, FosB or JunD in the epidermis did not provide evidence for a critical role of these proteins in normal skin (see Jochum et al. this issue). Moreover, speci®c deletion of c-Jun in cells of the stratum basale did not yield an obvious skin phenotype (R Zenz and EF Wagner, personal communication). These data suggest that single subunits (e.g. c-Jun, c-Fos) may not be required for skin development, or that other members of the protein family may functionally compensate their loss. The process of skin metabolism initiated by signals that trigger undierentiated, proliferative cells to undergo cell dierentiation and to ®nally become shed material of the corni®ed layer is fairly slow. Therefore, in light of the rapid and transient kinetics of expression and activity of AP-1 subunits in response to many extracellular signals (for review Angel and Karin, 1991; Karin et al., 1997) it is tempting to speculate that AP-1 activity may be required under conditions where the balance of keratinocyte proliferation and dierentiation has to be rapidly and temporally altered. The best example for the requirement of such a switch of genetic programs is the process of wound repair and tissue regeneration, also known as cutaneous wound healing. The healing of an adult wound is a very complex, dynamic and interactive process involving soluble mediators, blood cells, dermal cells (in particular ®broblasts which are responsible for synthesis of components of the extracellular matrix) and keratinocytes of the epidermis ( Figure 2 ; for review; Martin, 1997; Singer and Clark, 1999) .
The Ras/MAP/AP-1 pathway appears to play an important role in cell proliferation control in response to wounding since interference with Ras inhibits DNA synthesis, cell migration and induction of AP-1 members including c-Fos in bovine endothelial cells after mechanical wounding (Sosnowski et al., 1993) . On the other hand, in mice lacking c-Jun in keratinocytes tissue regeneration after wounding is not signi®cantly disturbed (R Zenz and EF Wagner, personal communication), excluding the absolute requirement of c-Jun in cell-autonomous regulation of keratinocyte proliferation, migration and dierentiation during wound healing in vivo. Nevertheless, there is strong evidence that AP-1 is critically involved in this process, since Jun, Fos and ATF proteins are at the receiving end of signalling pathways initiated by Figure 2 AP-1-dependent players of the cytokine network controlling the process of wound healing. Growth factors and cytokines secreted by various cell types during wound healing are shown. Only those, whose expression is regulated by AP-1, or whose activity in target cells depends, at least in part, on AP-1 activity, are considered. For a more detailed description of the wound healing process, see Martin, (1997) and Singer and Clark (1999) . On the left, the double paracrine network of epithelial-mesenchymal interaction established in an in vitro organotypic coculture system is highlighted. After wounding keratinocytes secrete IL-1 which induces expression of KGF and GM-CSF in ®broblasts. C-Jun and JunB regulate expression of both cytokines in ®broblasts in an antagonistic manner. An appropriate balance of KGF and GM-CSF is required for co-ordinated keratinocyte proliferation and dierentiation during reepithelialization of the epidermis AP-1 in skin biology P Angel et al cytokines and growth factors in appropriate target cells and, furthermore, since AP-1 is involved in the regulation of synthesis of the factors themselves. In normal and wounded skin, several growth factors and interleukins have been detected, such as IL-1, IL-6, IL-8, GM-CSF, TFG-a and TGF-b, NGF, PDGF as well as members of the FGF family (for review see SchroÈ der, 1995; Martin, 1997; Singer and Clark, 1999) . First evidence for an involvement of AP-1 in wound healing was provided by the fact that certain factors, such as EGF, FGF, members of the TGFb, TNF-a and interleukin protein families stimulate AP-1 activity through the activation of the MAP kinases JNK and p38, which, in turn hyperphosphorylate and thereby activate c-Jun and ATF-2, the main mediators of c-jun expression in response to cytokines and genotoxic agents. Upregulated gene expression resulting in enhanced levels of Jun and Fos proteins triggers alterations in the expression of AP-1 target genes, for example matrix metalloproteinases and IL-2 (Muegge et al., 1989; Borden and Heller, 1997) .
Second, a number of cytokines have been suggested to be potential AP-1 target genes. For example regulation of the human TNF promoter by phorbol esters depends in a variety of cell types on both an AP-1 and a juxtaposed PEA3/ETS-1 site (Kramer et al., 1995) . In myelomonocytic cells, AP-1 synergizes with C/EBPb in TNF-a expression. Interestingly, in these cells co-operation does not require the transactivation domain of c-Jun but may be explained by protein/protein interaction between c-Jun and c/EBPb leading to enhanced DNA binding (Zagariya et al., 1998) . In vitro binding studies and mutational analysis revealed the importance of Jun and Fos proteins in the expression of mouse M-CSF in ®broblasts and monocytes (Konicek et al., 1998) . AP-1 sites have been found in the promoter region of human and murine KGF and GM-CSF genes (Finch et al., 1995; Wang et al., 1994; Ye et al., 1996; Viebig, Szabowski and Angel, unpublished) . The importance of AP-1 for the induction of KGF promoter activity during wound healing and repression by glucocorticoids (Brauchle et al., 1995) has not been analysed in detail. In the case of the GM-CSF promoter, AP-1 exhibits its regulatory activity through functional synergism with other transcription factors including ETS-1, NF-kB (Wang et al., 1994; Thomas et al., 1997) , a Sp1-related complex (Ye et al., 1996) and NFAT (Masuda et al., 1993) . By contrast, AP-1-depended GM-CSF promoter activity can be repressed by the nuclear factor YY1 (Ye et al., 1996) . Functional synergism between AP-1, NF-IL-6 and NF-kB has been observed for the regulation of IL-8 expression (Roebuck, 1999) . Two adjacent AP-1 binding sites recognized by JunD and a Fosrelated protein mediate transcriptional activation of tissue factor (TF), the cellular initiator of the protease cascade leading to blood coagulation, by serum, as well as of de®ned growth factors, such as PDGF and FGF (Felts et al., 1995) . Interestingly, overexpression of cFos and JunD abrogates the requirement for serum in the stimulation of the TF promoter activity (Felts et al., 1995) . Yet, it remains to be determined whether in addition to c-Fos and JunD other AP-1 subunits are involved in TF expression. Finally, an ATF/CREBbinding site in the macrophage in¯ammatory protein 1 beta (MIP-1 beta) seems to control cell type-and LPSinduced expression of this gene in macrophages (Prott et al., 1995) .
AP-1 sites have been found in the promoter region of the ®broblast growth factor receptor 1 (Saito et al., 1992) , and IL-1 receptor antagonist promoter (Smith et al., 1992) , suggesting that AP-1 is also involved in the regulation of cytokine receptors thereby modulating the susceptibility of target cells for cytokine action.
As illustrated in Figure 2 cytokine-mediated cross talk involves a variety of cell types in the epidermis and in the mesenchyme which makes it very dicult to de®ne precisely the source of the cytokine of interest. However, a simpli®ed in vitro tissue engineered skin equivalent model mimicking tissue physiology has been established, in which the regulatory cross talk between keratinocytes and dermal ®broblasts can be investigated. In these organotypic cultures keratinocyte proliferation and dierentiation is maintained under the control of co-cultured dermal ®broblasts from human or mouse to form a three-dimensionally organized epithelium (Bell et al., 1981; Fusenig, 1994; Choi and Fuchs, 1990) . Keratinocytes form a typical epidermal tissue architecture expressing essentially all characteristic dierentiation markers including a basement membrane (Smola et al., 1998) . Importantly, this in vitro system mimics many aspects of the reepithelialization process during wound closure. This mesenchymal/epithelial interplay via diusible factors is initiated by keratinocyte-derived IL-1 acting on ®broblasts to induce the expression of growth factors such as KGF and GM-SCF in mouse ®broblasts acting back on human keratinocytes in a paracrine fashion. The speci®c contribution of AP-1-dependent cytokine expression in ®broblasts regulating keratinocyte proliferation and dierentiation was investigated using ®broblasts from c-jun or junB-de®cient mice (Szabowski et al., 2000) . Whereas c-jun 7/7 ®broblasts did not support keratinocyte growth, junB 7/7 ®broblasts caused enhanced keratinocyte growth and dierentiation. These phenotypes may be explained by the lack of constitutive and Il-1-induced expression of KGF and GM-CSF in c-jun 7/7 cells and enhanced constitutive expression of both genes in junB 7/7 cells. Growthinhibited thin epithelia in c-jun 7/7 ®broblasts containing cultures could be partially rescued by KGF to a proliferative but less dierentiating epithelium, whereas addition of both KGF and GM-CSF completely restored the wild-type phenotype. On the other hand, blocking antibodies to GM-CSF and IL-1 reduced the phenotype obtained by junB 7/7 ®broblasts. These data suggest that the relative abundance and activation state of a given AP-1 subunit in a non-cell autonomous, trans-regulatory fashion directs regeneration of the epidermis and maintenance of tissue homeostasis in skin (Szabowski et al., 2000) .
Fibroblast-derived KGF and GM-CSF, whose function in skin homeostasis has been con®rmed in mice (Rubin et al., 1989; Werner et al., 1992; Xing et al., 1997) represent the ®rst members of a potentially growing list of critical AP-1-regulated cytokines, which are produced by the various cell types during the dierent phases of the wound healing process (for review, Martin, 1997; Singer and Clark, 1999) . These factors very likely co-operate with ctyokines that are expressed in an AP-1 independent manner, e.g. members of the TGF-b family, their receptors (Frank et al., 1996) and downstream targets of the activin A pathway (Munz et al., 1999) .
In addition to autocrine and paracrine cytokine and growth factor action, there is convincing evidence that cell-cell and cell matrix interactions are important regulators of keratinocyte proliferation, migration and dierentiation. AP-1-regulated genes may also aect this type of regulatory mechanism. AP-1 binding sites have been identi®ed in the promoter regions of avian beta-3 integrin (Cao et al., 1993) , alpha2 (Zutter et al., 1994) , alpha5 (Corbi et al., 2000) alpha6 (Nishida et al., 1997) and alpha7 integrins (Ziober and Kramer, 1996) , laminin B1 (Matsui, 1996) , laminin gamma2-chain (Olsen et al., 2000) , decorin and tenascin-C (Mettouchi et al., 1997) . Only in some cases, speci®c AP-1 subunit compositions have been described, which may be responsible for regulation of these genes, such as JunD regulating expression of laminin gamma2 by HGF (Olsen et al., 2000) , and JunD/Fra-2 modulating basal and TGF-b-dependent laminin alpha 3A transcription (Virolle et al., 1998) .
Moreover, to allow tissue remodelling during wound healing the composition of the extracellular matrix has to be altered. This can be achieved by transcriptional regulation of cellular genes encoding ECM components as well as by proteolytic enzymes (particularly matrix metalloproteinases) and their inhibitors that control the ECM turnover on the post-translational level (for review: Borden and Heller, 1997; Vu and Werb, 2000) . Over the past years, a critical role for AP-1 in the regulation of ECM components has been established. For example, an AP-1 binding site mediates expression of human alpha2 (I) collagen (COL1A2) gene by TGFb and TNF-a (Chung et al., 1996) . Expression of syndecan-1, a cell surface heparan sulphate proteoglycan that binds growth factors, is activated during cutaneous wound healing through a so-called AP-1-driven FGF-inducible response element (FiRE). Interestingly, FiRE activity is selectively upregulated in migrating keratinocytes at the edge of the wound and is persistent until completion of the re-epithelialization process. Although the exact composition of AP-1 complexes binding to this element has not yet been identi®ed, modulation of AP-1 complexes is mediated by members of the MAP kinase family including ERKs and p38 (Jaakkola et al., 1998) .
AP-1 plays a dominant role in the transcriptional activation of the majority of matrix-metalloproteinases (MMPs) that are required for cell migration, ECM degradation and tissue reorganization during the wound healing process. Basal transcription as well as activation of MMP promoters in response to phorbol esters, cytokines, growth factors and cell matrix interactions and altered cell-cell contacts require the speci®c interaction of AP-1 and ETS proteins (for review see Benbow and Brinckerho, 1997) . In general, MMPs are not constitutively expressed in skin but are induced temporarily in response to the above mentioned exogenous signals to trigger the proteolytic remodelling of the ECM in physiological and pathological situations e.g. tissue morphogenesis, tissue repair but also dermal photoaging and tumour cell invasion (for review KaÈ haÈ ri and Saarialho-Kere, 1997). In acute murine excisional skin wounds interstitial collagenase (MMP-1; MMP-13), MMP-9, MMP-3, MMP-10 and their physiological inhibitor TIMP-1 are strongly induced showing a unique spatial and temporal transcription pattern (Madlener et al., 1998) . Tissue culture as well as animal studies have provided evidence for the importance of the AP-1 target genes MMP-1 and MMP-3 during wound healing in keratinocyte migration (MMP-1; Lund et al., 1999) and wound contraction, respectively (MMP-3; Bullard et al., 1999) .
Involvement of AP-1 subunits in photoaging
According to the function of the skin to serve as a protective barrier against the environment, such as ultraviolet irradiation from sunlight, skin cells actively respond to such signals by changing their repertoire of gene expression to prevent radiation-induced damage. Long-term exposure to UV causes premature skin aging (photoaging), in the course of which the symptoms include leathery texture, mottled pigmentation and wrinkles. There is strong evidence that this process is driven by major changes in gene expression of ®broblasts in the dermal compartment (Bernerd and Asselineau, 1998) . This includes induction of AP-1-regulated matrix metalloproteinases, particularly interstitial collagenase (MMP-1), stromelysin (MMP-3) and gelatinase B (MMP-9; Fisher et al., 1997) . In agreement with the critical role of AP-1 in the transactivation of these genes by UV, transcription of the c-jun, junB and c-fos genes is also enhanced upon UV irradiation (Gillardon et al., 1994; Fisher et al., 1999; Soriani et al., 2000; Shaulian and Karin, this issue) . However, there is evidence that, depending on the wavelength of the UV light, the eciency of induction diers among the Fos and Jun members (Ariizumi et al., 1996) . Importantly, pre-existing and newly synthesized c-Jun protein becomes eciently hyperphosphorylated, most likely by members of the JNK/SAPK kinase family (Ramaswamy et al., 1998; Fisher et al., 1999) . Activation of c-Jun seems also to depend on PKCzeta, because pre-treatment of mouse skin with PKCzeta antisense oligonucleotides impaired UV induced c-Jun-speci®c gene expression (Huang et al., 2000) . Interestingly, pre-treatment of cells with retinoic acid, which diminishes the eciency of photoaging inhibits UV-dependent transcriptional acti-AP-1 in skin biology P Angel et al vation of MMPs. The repression seems to be mediated by an accelerated breakdown of the c-Jun protein via the ubiquitin-proteasome pathway (Fisher et al., 1999) . However, superfusion of rat skin with c-fos antisense oligonucleotides did not signi®cantly reduce the formation of sunburn cells in the UV-irradiated epidermis (Gillardon et al., 1994) .
Role of AP-1 in tumourigenesis and other skin diseases
The ability of speci®c members of the Jun and Fos protein family, as well as their retroviral derivatives, to transform tissue culture cells and to induce tumours in the animal (avian, rat, mouse) is well established (see van Dam and Castellazzi and Jochum et al., this issue).
There is evidence that changes in AP-1 expression and activity correlate with dierent stages of melanoma development and progression (Rutberg et al., 1994) . It was, however, the analysis of AP-1 function in keratinocyte cell lines and in epidermal tumours of the mouse, which has contributed considerably to our current knowledge on the function of AP-1 in tumourigenesis. Dierent tumour model systems of mouse skin have become available:
Formation of squamous cell carcinoma can be induced in hairless mice upon chronical exposure to UV-B irradiation. While a single exposure leads to a transient upregulation of c-fos, c-jun and c-myc, high constitutive expression of c-fos, c-myc and Ha-ras was observed in the tumour cells (Sato et al., 1997) . Interestingly, application of the monoterpene perillyl alcohol (POH) inhibited tumour incidence and UV-Binduced AP-1 activity in mouse skin (Barthelman et al., 1998) . The speci®c contribution of these proteins in the induction of skin photocarcinogenesis still remains to be con®rmed by functional assays.
Skin papillomas can be induced with very high eciency upon constitutive activation of the Ras pathway in basal keratinocytes . Tumour formation is impaired in mice expressing a cJun mutant, which lacks the phosphoacceptor sites for JNK , which strongly suggests that activation of c-Jun and c-Jun-dependent target genes is critically involved in the development of skin papillomas.
Expression of bovine papilloma virus (BPV) in mouse dermal ®broblasts induces the formation of mild and aggressive ®bromatosis, and ®brosarcoma. The latter two stages are characterized by strongly enhanced expression of c-Jun and JunB, but not JunD and Fos (Bossy-Wetzel et al., 1992) . Overexpression of c-Jun or JunB, but not JunD, in cells of mild ®bromatosis induced anchorage independence and changes in the cell shape, suggesting that both proteins may function as progression factors at intermediate stages of tumorigenesis. Fibrosarcomas have been observed also in v-Jun transgenic mice, which exhibit high basal level expression of the transgene in ®broblasts (Schuh et al., 1990) . However, tumour formation depends on obligatory wounding, suggesting that, in contrast to BPV, transformation by v-Jun requires co-operative action with other yet unknown factors.
When targeted to the basal cells of the epidermis, expression of human papilloma virus 16 (HPV-16) leads to progressive squamous epithelial neoplasia, which is accompanied by alterations in the expression of K5, K10, K14 and ®laggrin (Arbeit et al., 1994) . Products of HPV (E6, E7) may directly or indirectly aect AP-1 activity, resulting in changes in gene expression and keratinocyte proliferation and dierentiation (Antinore et al., 1996; Shino et al., 1997) . On the other hand, transcriptional activity of HPV-16 and other serotypes, e.g. HPV-18 and HPV-11 depends on AP-1 binding sites (Cripe et al., 1990; Thierry et al., 1992; Zhao et al., 1997) . Exempli®ed by HPV-18 there is increasing evidence that speci®c AP-1 subunits dier in their activity to either activate or trans-repress HPVlinked carcinogenesis of the uterine cervix (Thierry et al., 1992; Soto et al., 1999) .
The contribution of AP-1 subunits to premalignant conversion and malignant progression of epidermal cells is best documented by the initiation-promotion protocol of mouse multistage skin carcinogenesis, which ranks among the best studied in vivo approaches in experimental cancer research (for review see Bowden et al., 1994; Brown and Balmain, 1995; Yuspa, 1998) . Upon treatment of the skin with a single dose of mutagen (e.g. DMBA), followed by repeated application of tumour promoters, such as the phorbol ester 12-0-tetradecanoylphorbol-13-acetate (TPA), benign papillomas develop, some of which will enter malignant progression to squamous cell carcinomas. In mice lacking c-fos the development of malignant skin tumours from papillomas induced by treatment with TPA is blocked at the transition from benign to malignancy (Saez et al., 1995) . The eciency of formation of papilloma did not dier from wild-type mice, but papillomas quickly hyperkeratinized. In agreement with these data transgenic mice expressing a transdominant-negative version of c-Jun (TAM67) are resistant to DMBA-TPA induced skin tumorigenesis (Young et al., 1999) . Surprisingly, transgenic mice expressing v-Fos under the control of the human keratin-1 promoter exhibit hyperplasia, hyperkeratosis and squamous papillomas in wounded ears (Greenhalgh et al., 1993) , suggesting that both overexpression and loss of Fos activity interferes with skin homeostasis. An additional major advantage of this carcinogenesis model is the availability of mouse keratinocyte cell lines that represent each of the intermediate stages in tumour development. In these cells constitutive AP-1 binding and transactivating ability of cells of the malignant, but not benign state of the tumour was observed . Moreover, high levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins and a reduction in JunB expression correlate with malignancy (Joselo and Bowden, 1997; Zoumpourlis et al., 2000) . Overexpression of c-Fos in the papilloma cell line seems to be sucient for malignant conversion (Greenhalgh and Yuspa, 1988) , whereas expression of a transdominant negative mutant version of c-Jun in malignant cells inhibited expression of AP-1-dependent reporter genes and the ability of the cells to form tumours in nude mice . These results are in good agreement with data obtained in two variants of the mouse keratinocyte cell line JB6, which are either promotion-sensitive (P+) or promotion resistant (P7) to TPA-induced transformation. TPA-induced expression of c-Jun is reduced in P7 cells and overexpression of c-Jun increased the probability of progression in P+, but not in P7 cells (Watts et al., 1995) . Overexpression of a dominant negative c-Jun mutant blocked TPA-induced AP-1 activity, cell transformation and invasion (Dong et al., 1994 . Block of tumorigenesis is accompanied by a loss of TPAinduced expression of MMPs, such as interstitial collagenase (MMP-13), stromelysin-1 (MMP-3, stromelysin-2 (MMP-10), gelatinase A (MMP-2) and MT1-MMP (MMP-14; Dong et al., 1997) . The TPA-induced cellular response is mediated by MAP kinases, since expression of transdominant negative version of ERK2 inhibits AP-1-dependent gene expression and neoplastic transformation (Watts et al., 1998) .
Co-treatment with retinoic acid (Huang et al., 1997) or steroid hormones, particularly glucocorticoids (Belman and Troll, 1972) , can eciently interfere with chemically-induced tumour formation in the mouse. TPA-dependent transcriptional upregulation of MMP-3 and MMP-13 is similarly blocked by glucocorticoids (Tuckermann et al., 1999) . Induction of these genes is abolished with similar eciency in wild-type and in GR dim mice expressing a DNA-binding-defective mutant version of GR, demonstrating that the DNA binding-dependent function of GR is fully dispensable for repression of AP-1 activity in vivo and that DNAbinding-independent functions of the GR are responsible for the antitumour promoting activity of glucocorticoids (Tuckermann et al., 1999) . Similarly, the repression function of the retinoic acid receptor, but not the activation of retinoic acid responsive genes is required for the antitumour promotion eect of retinoic acid (Huang et al., 1997) . Remarkable results of a recent study suggest that the eciency of antiin¯ammatory agents and cancer chemoprevention may also be ascribed to an impaired recruitment and/or function of in¯ammatory cells that supply the AP-1 target gene MMP-9. Analysis of the role of MMP-9 during carcinogenesis in K14-HPV16 transgenic mice and in mice lacking MMP-9 revealed that MMP-9 expressed by in¯ammatory cells is functionally involved in the regulation of oncogene-induced keratinocyte hyperproliferation, progression to invasive cancer and end-stage malignant grade epithelial carcinomas (Coussens et al., 2000) . Thus, tumour development and progression are complex multicellular processes, in which normal cells, such as in¯ammatory cells, or normal constituents of wound repair are conscripted to signi®cantly contribute to the tumour phenotype (Boudreau and Bissell, 1998; Hanahan and Weinberg, 2000) . Moreover, there seems to exist a quantitative requirement or threshold for an acute neoplastic response and its progression to malignant stages which in addition can depend on the nature of the target cell as it has been demonstrated for v-Jun-mediated wound tumorigenesis (Shalaby et al., 1994) .
Evidence for trans-regulatory functions of cellular Jun proteins in the regeneration of the epidermis and maintenance of tissue homeostasis comes from the analysis of a reconstituted skin by combining primary human keratinocytes and mouse wild-type, c-jun 7/7 or junB 7/7 ®broblasts described above (Szabowski et al., 2000;  Figure 2 ). An aberrant or disturbed balance between cytokines may also be implicated in pathological diseases in human, such as lichen planus, psoriasis or dermato®brosis (Lever, 1983) . Histologically cutaneous lichen planus is characterized by epidermal hypergranulosis (a pronounced stratum granulosum with high amounts of keratohyalin granula), irregular acanthosis, hyperkeratosis, dermal dibrosis and a dense in®ltrate (Stefanidou et al., 1999) . By contrast, absence of granular cells, hyperproliferation and parakeratosis is observed in psoriatic epidermis (Lever, 1983) . In vitro, normal keratinocytes develop psoriatic-skin like epidermal phenotypes when grown on ®broblasts from psoriatic lesions (Saiag et al., 1985) , providing evidence that the epidermal alterations in psoriasis and dermato®broma are caused by changes in the underlying dermal ®broblasts. The critical interplay between ®broblasts and keratinocytes can also be exempli®ed in dermato®bromas where a signi®cant hyperplasia of the epidermis can be observed overlying the benign ®broblastic tumour nodule. Thereby, the ®brotic cells stimulate the epidermis in a fashion similar to that of embryonic mesenchyme (Lever, 1983) .
Enhanced DNA binding activity of AP-1 was observed in ®broblasts from recessive dystrophic epodermolysis bullosa patients, which may be responsible for elevated mRNA and protein levels of AP-1 target genes, such as MMP-1 and MMP-3 (Unemoria et al., 1994) . In ®broblasts of the tight skin (TSK) mouse, representing a model of ®brosis characterized by exaggerated connective tissue accumulation in skin and visceral organs, increased levels of alpha 1(I) and alpha 1 (III) chain mRNA were found. This was explained by a loss of the negatively acting AP-1 complex binding to the promoter of these genes (Philips et al., 1995) . The identi®cation of the speci®c subunits of this complex, however, remains to be determined. Similarly, the nature of the AP-1 subunits exhibiting enhanced DNA binding to the collagenase promoter in ®broblasts derived from patients with cutis laxa (Hatamochi et al., 1996 ) is yet unknown. Enhanced mRNA and protein levels of c-Jun and cFos were found in keloids and hypertrophic scars representing a model of altered wound healing characterized by hyperproliferation of dermal ®bro-blasts and accelerated production of components of the extracellular matrix (Teofoli et al., 1999) .
Summary and outlook
AP-1 participates in key physiological and pathophysiological processes due to its central role as a cellular switch of genetic programs in response to extracellular signals. The distinct expression pattern of AP-1 subunits in the skin as well as the large number of AP-1 target genes in epidermal cells indicate that AP-1 plays a pivotal role in normal and pathological skin physiology. Even though the loss of single AP-1 subunits in mice did not result in obvious skin phenotypes, experiments with in vitro reconstituted skin provided direct evidence for the orchestrated antagonistic action of c-Jun and JunB to control cytokine-regulated mesenchymal-epidermal interaction in normal skin. Moreover, the regulatory function of AP-1 in wound healing, photoaging and tumorigenesis is demonstrated by numerous studies in tissue culture cells and mouse models. Taken together, AP-1 transactivation of target genes contributes to both protective and pathological responses in individual cells or tissues, including the skin.
The analysis of transgenic mouse models and of in vitro tissue engineered skin equivalent models using genetically altered AP-1 subunit-de®cient cell types will be the focus of future studies. As more data will be generated, our current knowledge on the individual functional involvement of AP-1 subunits in skin homeostasis, wound healing and skin carcinogenesis will be enhanced.
The design of novel therapeutic strategies and potential clinical applications for skin diseases and cancer will depend on the scienti®c progress made in de®ning cell-type and stimulus-speci®c activation modes of individual AP-1 subunits, on the characterization of AP-1 subunit-speci®c target genes and genetic programs within a given cell type at a certain dierentiation state. The method of choice will be the use of comprehensive array and bioinformatic tools to compare the gene expression patterns for example of keratinocytes located in the dierent epidermal layers, cells from non-treated and UV-treated skin, or cancer cells of dierent stages of tumour progression. The major challenge, however, will be identi®cation of those changes that are important, e.g. for cancer development and progression. Clearly, the availability of the broad spectrum of both in vivo and in vitro experimental approaches described above represents a powerful selection system to rapidly ®lter the enormous number of dierentially expressed genes and to focus on the most promising tumour-associated genes. The detailed analysis of known and newly identi®ed AP-1 target genes in such model systems oers the unique opportunity to con®rm the importance of these genes as potential drug targets and will proved a molecular basis by which alterations in AP-1 subunit composition and activity may act together in regulating key aspects of normal or pathological phenotype development and maintenance.
